Behzad Aghazadeh
Director at Scribe Therapeutics · 3 reported transactions in 1 company · latest trade Jul 28, 2026
Their record
No purchases old enough to measure yet.
Their trades
Bought | Jul 28, 2026 | Jul 28, 2026 close $18.06 → Oct 28, 2026 close $17.54. S&P 500 +3.9% over the same days. | ||
Bought | Jul 24, 2026 | Jul 24, 2026 close $21.65 → Oct 28, 2026 close $17.54. S&P 500 +4.2% over the same days. | ||
Bought | Jul 24, 2026 | Jul 24, 2026 close $21.65 → Oct 28, 2026 close $17.54. S&P 500 +4.2% over the same days. |
BoughtScribe Therapeutics
$144.3K
Jul 28, 2026 close $18.06 → Oct 28, 2026 close $17.54. S&P 500 +3.9% over the same days.
BoughtScribe Therapeutics
$1.12M
Jul 24, 2026 close $21.65 → Oct 28, 2026 close $17.54. S&P 500 +4.2% over the same days.
BoughtScribe Therapeutics
$35M
Jul 24, 2026 close $21.65 → Oct 28, 2026 close $17.54. S&P 500 +4.2% over the same days.